Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 ...

Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most ...

Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Goldman Sachs analyst Michael Ng revised the price target on Comcast Corporation (NASDAQ:CMCSA) shares, reducing it from ...

Goldman Sachs stock is not overvalued as growth in revenue and EPS is impressive. Click here to find out why I believe GS is ...

In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash ...

Goldman's president and chief operating officer was also awarded a retention bonus of $80 million in restricted stock, the ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...